- Patent Title: Oral formulations of cytidine analogs and methods of use thereof
-
Application No.: US17533033Application Date: 2021-11-22
-
Publication No.: US11571436B2Publication Date: 2023-02-07
- Inventor: Jeffrey B. Etter , Mei Lai , Jay Thomas Backstrom
- Applicant: Celgene Corporation
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: A61K31/706
- IPC: A61K31/706 ; A61K9/20 ; A61K9/28 ; A61K31/7068 ; A61K47/10
Abstract:
The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
Public/Granted literature
- US20220079964A1 ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF Public/Granted day:2022-03-17
Information query
